Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Radiation Oncology cung cấp cho các bạn kiến thức về ngành y đề tài: " High-risk surgical stage 1 endometrial cancer: analysis of treatment outcome. | Radiation Oncology BioMed Central Research High-risk surgical stage I endometrial cancer analysis of treatment outcome Gustavo A Viani Barbara F Patia Antonio C Pellizzon Marcel D De Melo Paulo E Novaes Ricardo C Fogaroli Maria A Conte and Joao V Salvajoli Open Access Address Department of Radiation Oncology Hospital do Cancer Sao Paulo Brazil Email Gustavo AViani - gusviani@ Barbara F Patia - barbarafrancine@ Antonio C Pellizzon - marcelmelo@ Marcel D De Melo - marcelmelo@ Paulo E Novaes - marcelmelo@ Ricardo C Fogaroli - rcfogaroli@ Maria A Conte - contemaia@ Joao V Salvajoli - jvsalvajoli@ Corresponding author Published 03 August 2006 Received 03 June 2006 Radiation Oncology 2006 1 24 doi 174 -717X-1-24 Accepted 03 August 2006 This article is available from http content 1 1 24 2006 Viani et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Purpose To report the relapse and survival rates associated to treatment for patients with stage IC grade 2 or grade 3 and IB grade 3 diseases considered high risk patients group for relapse. Materials and methods From January 1993 to December 2003 106 patients with endometrial cancer stage I were managed surgically in our institution. Based on data from the medical records 106 patients with epithelial endometrial cancer met the following inclusion criteria stage IC grade 2 or 3 and IB grade 3 with or without lymphovascular invasion. Staging was defined according to the FIGO surgical staging system. Postoperative adjuvant radiotherapy consisted of external beam pelvic radiation vaginal brachytherapy alone or both. The median age was 65 years range 32-83 years lymph node dissection .